Miromatrix Medical Inc. Contracts & Agreements

Contingent Value Rights Agreement, dated as of December 12, 2023, by and between United Therapeutics Corporation and Continental Stock Transfer & Trust Company (Filed With SEC on December 18, 2023)

Agreement and Plan of Merger, dated as of October 29, 2023, by and among Miromatrix Medical Inc., United Therapeutics Corporation, and Morpheus Subsidiary Inc (Filed With SEC on October 30, 2023)

Thirteenth Amendment to the License Agreement, dated July 17, 2023, by and between Miromatrix Medical Inc. and Mayo Foundation for Medical Education and Research (Filed With SEC on August 14, 2023)

Twelfth Amendment to the License Agreement, dated May 7, 2023, by and between Miromatrix Medical Inc. and Mayo Foundation for Medical Education and Research (Filed With SEC on August 14, 2023)

Eleventh Amendment to the License Agreement, dated November 1, 2022, by and between Miromatrix Medical Inc. and Mayo Foundation for Medical Education and Research (Filed With SEC on March 31, 2023)

Underwriting Agreement, dated as of March 7, 2023, by and between the Company and Piper Sandler & Co., as representative of the underwriters (Filed With SEC on March 8, 2023)

Tenth Amendment to the License Agreement, dated March 31, 2022, by and between Miromatrix Medical Inc. and Mayo Foundation for Medical Education and Research (Filed With SEC on May 16, 2022)

Nineth Amendment to the License Agreement, dated October 21, 2021, by and between Miromatrix Medical Inc. and Mayo Foundation for Medical Education and Research (Filed With SEC on March 30, 2022)

Description of Securities of Miromatrix Medical Inc (Filed With SEC on March 30, 2022)

Employment Agreement, dated March 1, 2022, with James M. Douglas (Filed With SEC on March 1, 2022)

Form of Employee Confidentiality, Non-Competition and Non-Solicitation Agreement (Filed With SEC on November 15, 2021)

Eighth amendment to the Mayo License Agreement dated October 21, 2021 between the Company and Mayo Foundation for Medical Education and Research (Filed With SEC on November 15, 2021)

Employment Agreement, dated August 31, 2021, by and between Miromatrix Medical Inc. and Brian Niebur (Filed With SEC on September 3, 2021)

Employment Agreement, dated August 31, 2021, by and between Miromatrix Medical Inc. and Jeff Ross (Filed With SEC on September 3, 2021)

Multi-Tenant Industrial Triple Net Lease, dated August 2, 2021, by and between the Company and B9 Polar Prairie Oaks Corporate LLC (Filed With SEC on August 5, 2021)

Form of Common Stock Warrant issued to Randy Hines under the 2010 Plan (Filed With SEC on June 17, 2021)

Miromatrix Medical Inc. 2021 EQUITY INCENTIVE PLAN Restricted Stock Unit Award Agreement (Filed With SEC on June 16, 2021)

Form of Employee Restricted Stock Unit Award Agreement (Filed With SEC on June 16, 2021)

Form of Employee Non-Qualified Stock Option Agreement (Filed With SEC on June 16, 2021)

Form of Director Non-Qualified Stock Option Agreement (Filed With SEC on June 16, 2021)

Cheshire Note and Warrant Purchase Agreement, dated March 6, 2020, between the Registrant and Cheshire MD Holdings, LLC (Filed With SEC on June 16, 2021)

Cheshire Note, dated March 6, 2020, between the Registrant and Cheshire MD Holdings, LLC (Filed With SEC on June 16, 2021)

Specimen Common Stock Certificate of Registrant (Filed With SEC on June 16, 2021)

Form of Indemnification Agreement by and between the Registrant and its individual directors and officers (Filed With SEC on June 10, 2021)

Form of Underwriting Agreement (Filed With SEC on June 10, 2021)

Series C Purchase Agreement, dated May 3, 2021, among the Registrant, Baxter Healthcare Corporation and CareDx, Inc (Filed With SEC on May 28, 2021)

Miromatrix Inc. 2021 Employee Stock Purchase Plan (Filed With SEC on May 28, 2021)

Miromatrix Inc. 2021 Stock Incentive Plan (the 2021 Plan) (Filed With SEC on May 28, 2021)

Employment Agreement, dated March 3, 2017, between the Registrant and Jeff Ross (Filed With SEC on May 28, 2021)

Miromatrix Inc. 2019 Stock Incentive Plan (the 2019 Plan) (Filed With SEC on May 28, 2021)

Miromatrix Inc. 2010 Stock Incentive Plan (the 2010 Plan) (Filed With SEC on May 28, 2021)

Series C Side Letter, dated May 21, 2021, among the Registrant, Baxter Healthcare Corporation and CareDx, Inc (Filed With SEC on May 28, 2021)

License Agreement, dated September 15, 2013, between the Registrant and Mayo Foundation for Medical Education and Research (Filed With SEC on May 28, 2021)

Series B Preferred Stock Investor Rights Agreement, dated October 8, 2013, between the Registrant and certain investors (Filed With SEC on May 28, 2021)

Series B-2 Preferred Stock Investor Rights Agreement, dated October 16, 2017, between the Registrant and certain investors (Filed With SEC on May 28, 2021)

Cheshire Note, dated March 6, 2020, between the Registrant and Cheshire MD Holdings, LLC (Filed With SEC on May 28, 2021)

Cheshire Initial Warrant, dated March 6, 2020, between the Registrant and Cheshire MD Holdings, LLC (Filed With SEC on May 28, 2021)

Cheshire Form of Subsequent Warrant, between the Registrant and Cheshire MD Holdings, LLC (Filed With SEC on May 28, 2021)

Form of Common Stock Warrant issued by the Registrant to certain investors under the 2010 Plan (Filed With SEC on May 28, 2021)

Form of Stock Option issued by the Registrant to certain of its directors, officers and employees under the 2010 Plan (Filed With SEC on May 28, 2021)

Form of Stock Option issued by the Registrant to certain of its directors, officers and employees under the 2019 Plan (Filed With SEC on May 28, 2021)

Exclusive Patent License Agreement, dated February 4, 2010, between the Registrant and the University of Minnesota (the Minnesota License Agreement) (Filed With SEC on May 28, 2021)

First Amendment to the Minnesota License Agreement, dated November 17, 2010, between the Registrant and the University of Minnesota (Filed With SEC on May 28, 2021)

Second Amendment to the Minnesota License Agreement, dated March 12, 2013, between the Registrant and the Regents of the University of Minnesota (Filed With SEC on May 28, 2021)

Third Amendment to the Minnesota License Agreement, dated December 11, 2014, between the Registrant and the Regents of the University of Minnesota (Filed With SEC on May 28, 2021)

Fourth Amendment to the Minnesota License Agreement, dated September 15, 2016, between the Registrant and the Regents of the University of Minnesota (Filed With SEC on May 28, 2021)

Fifth Amendment to the Minnesota License Agreement, dated February 21, 2021, between the Registrant and the Regents of the University of Minnesota (Filed With SEC on May 28, 2021)

License Agreement, dated January 1, 2011, between the Registrant and Mayo Foundation for Medical Education and Research (Filed With SEC on May 28, 2021)

Series A Preferred Stock Investor Rights Agreement, dated November 22, 2011, between the Registrant and certain investors (Filed With SEC on May 28, 2021)

License Agreement, dated December 1, 2014, between the Registrant and Mayo Foundation for Medical Education and Research (the Mayo License Agreement) (Filed With SEC on May 28, 2021)

First Amendment to the Mayo License Agreement, dated September 20, 2016, between the Registrant and Mayo Foundation for Medical Education and Research (Filed With SEC on May 28, 2021)

Second Amendment to the Mayo License Agreement, dated September 12, 2017, between the Registrant and Mayo Foundation for Medical Education and Research (Filed With SEC on May 28, 2021)

Third Amendment to the Mayo License Agreement, dated February 21, 2017, between the Registrant and Mayo Foundation for Medical Education Research (Filed With SEC on May 28, 2021)

Fourth Amendment to the Mayo License Agreement, dated January 24, 2018, between the Registrant and Mayo Foundation for Medical Education and Research (Filed With SEC on May 28, 2021)

Fifth Amendment to the Mayo License Agreement, dated May 12, 2019, between the Registrant and Mayo Foundation for Medical Education and Research (Filed With SEC on May 28, 2021)

Sixth Amendment to the Mayo License Agreement, dated February 28, 2020, between the Registrant and Mayo Foundation for Medical Education and Research (Filed With SEC on May 28, 2021)

Seventh Amendment to the Mayo License Agreement, dated February 26, 2021, between the Registrant and Mayo Foundation for Medical Education and Research (Filed With SEC on May 28, 2021)

Sub-License Agreement, dated October 1, 2013, between the Registrant and Texas Heart Institute (Filed With SEC on May 28, 2021)

First Amendment to the Sub-License Agreement, dated April 1, 2014, between the Registrant and Texas Heart Institute (Filed With SEC on May 28, 2021)

Second Amendment to the Sub-License Agreement, dated September 25, 2018, between the Registrant and Texas Heart (Filed With SEC on May 28, 2021)

The Stock Purchase Agreement, dated October 14, 2020, between the Registrant and Reprise Biomedical Inc (Filed With SEC on May 28, 2021)

Patent and Know-How License Agreement, dated June 30, 2019, between the Registrant and Reprise Biomedical Inc (Filed With SEC on May 28, 2021)

First Amendment to the Patent and Know-How License Agreement, dated October 3, 2019, between the Registrant and Reprise Biomedical, Inc (Filed With SEC on May 28, 2021)

Second Amendment to the Patent and Know-How License Agreement, dated February 22, 2021, between the Registrant and Reprise Biomedical, Inc (Filed With SEC on May 28, 2021)

Category

Industry

Companies

Contracts

Miromatrix Medical Inc. Contracts & Agreements